Richard Klausner, M.D.
Affiliations: | NIH/NCI |
Area:
cell biology and metabolismWebsite:
http://womenscancerresearchfund.org/81/richard-d-klausner-m-d/Google:
"Richard D. Klausner"Bio:
http://www.nasonline.org/member-directory/members/64199.html
Children
Sign in to add trainee| Juan S. Bonifacino | post-doc | NIH/NCI | |
| Stephen Lee | post-doc | National Cancer Institute, NIH, Bethesda | |
| Arnim Pause | post-doc | NIH/NCI | |
| Jennifer Lippincott-Schwartz | post-doc | 1990 | NIH (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pjura WJ, Kleinfeld AM, Klausner RD, et al. (2010) Fatty Acid perturbation of a membrane protein-lipid interaction: a terbium (tb) study. Biophysical Journal. 37: 69-71 |
| Brower CS, Sato S, Tomomori-Sato C, et al. (2002) Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase. Proceedings of the National Academy of Sciences of the United States of America. 99: 10353-8 |
| Maranchie JK, Vasselli JR, Riss J, et al. (2002) The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell. 1: 247-55 |
| de Paulsen N, Brychzy A, Fournier MC, et al. (2001) Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 98: 1387-92 |
| Iwai K, Yamanaka K, Kamura T, et al. (1999) Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proceedings of the National Academy of Sciences of the United States of America. 96: 12436-41 |
| Pause A, Peterson B, Schaffar G, et al. (1999) Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Proceedings of the National Academy of Sciences of the United States of America. 96: 9533-8 |
| Lee S, Neumann M, Stearman R, et al. (1999) Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Molecular and Cellular Biology. 19: 1486-97 |
| Pause A, Lee S, Lonergan KM, et al. (1998) The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proceedings of the National Academy of Sciences of the United States of America. 95: 993-8 |
| Pause A, Lee S, Worrell RA, et al. (1997) The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proceedings of the National Academy of Sciences of the United States of America. 94: 2156-61 |
| Pause A, Aso T, Linehan WM, et al. (1996) Interaction of von Hippel-Lindau tumor suppressor gene product with elongin. Methods in Enzymology. 274: 436-41 |